Resistell again among TOP 10 best Swiss startups 2021

To learn more about how antibiotic resistance and antibiotic tolerance are hindering our ability to slow the spread of infectious diseases read an excellent review article in EBR by Dr. Alex Sturm, Senior Scientist at Resistell.

The Resistell's device tests antibiotic resistance faster than ever before. A drop of bacteria is placed on a tip of cantilever sensor which records nano-scale vibrations of living cells. The measurements reveal whether an antibiotic worked or the microbes are still alive.

Resistell AG has started the Performance Evaluation Study (PES) of its groundbreaking nanomotion technology at Lausanne University Hospital (CHUV)

How do you find the most effective antibiotic for a patient as quickly as possible? The start-up "Resistell" has developed a new type of test for antibiotic resistance. Read more about this test in Schwizerische Ärztezeitung.

On the International Day of Women and Girls in Science, European Innovation Council invited Danuta Cichocka, Resistell CEO, the female scientist and entrepreneur, to share her story about her passion in life science in an interview.

Die Covid-Pandemie hat alle Bereiche des Lebens erfasst. Auch die Startup- und Gründerszene musste mit der Situation umgehen und unter erschwerten Bedingungen die Projekte weiter führen und antreiben. Gleichzeitig aber hat Corona als Katalysator gewirkt für disruptive Ideen, für Innovation und Unternehmergeist.

The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.

The World Antimicrobial Awareness Week (WAAW) starts today, and this year’s slogan highlights the importance of encouraging best practices when it comes to using antimicrobials. Our portfolio company Resistell is helping to reduce the spreading of antibiotic resistance with their rapid Antimicrobial Susceptibility Testing.

Resistell, the start-up developing world’s fastest phenotypic antibiotic susceptibility test (rapid AST) won the Special Life Science Award in Swiss Innovation Challenge. The prestigious award is a great honour for Resistell and a huge confirmation for the whole team and the product itself.

This year we’ve made a spectacular leap and **ranked 8th**, joining the league of TOP10 most promising start-ups in Switzerland in 2020.

Nanomechanical Sensors as a Tool for Bacteria Detection and Antibiotic Susceptibility Testing

Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.

We invite you to study the "Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection" published in TrAC Trends in Analytical Chemistry, Volume 127, June 2020 by Jiri Dietvorst, Luïsa Vilaplana, Naroa Uria, Maria-Pilar Marco, Xavier Muñoz-Berbel.